were still learning about the long-term effects, so research is ongoing
Some studies suggest that tirzepatide may lead to greater average weight loss than semaglutide, though long-term outcomes are still being studied
The Journal of clinical endocrinology and metabolism
Novo, which is known for its hit Wegovy and Ozempic injections for obesity and diabetes respectively, said the launch opens new possibilities for the more than 100 million Americans living with obesity
This relentless focus on quality ensures that when you follow the correct reconstitution protocol, the solution in your vial is exactly what it's supposed to bea pure, potent, and reliable tool for your research
Cumulative receptor engagement and therefore weight loss is determined by total weekly dose, not peak height